Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (67)
- Manufacturing (22)
- COVID-19 (18)
- Sunscreens (12)
- Compliance and enforcement (11)
- Labelling and packaging (11)
- Legislation (9)
- Advertising (8)
- Shortages and supply disruptions (8)
- Committees and advisory bodies (7)
- Scheduling (national classification system) (6)
- Vaping hub (6)
- Medicinal cannabis hub (4)
- Clinical trials (2)
- Import and export (2)
- Unique Device Identification (UDI) hub (2)
- Weight loss products (2)
- Cosmetics (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
380 result(s) found, displaying 176 to 200
-
News articlesThe TGA has updated the Australian Regulatory Guidelines for Sunscreens (ARGS) to align with the data requirements for all ingredients proposed to be included in the Therapeutic Goods (Permissible Ingredients) Determination
-
News articlesThe TGA will recognise the extended transition for the European Union Medical Device Regulation (EU MDR).
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesWe are conducting surveys to collect information about medical devices manufactured at the point-of-care.
-
News articlesThe TGA has approved the first commercially supplied test kit for the detection of Mpox (monkeypox) virus.
-
News articlesFind out about new transition arrangements for dual labelled ingredient names.
-
News articlesEssential Principle 7 now mentions nanomaterials explicitly (see EP 7.7).
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesFrom 22 March 2023 changes to the Therapeutic Goods Act 1989 will help alleviate the effects of medicine shortages on patients.
-
News articlesProvisional registration of Tecentriq (atezolizumab) for the treatment in mTNBC will lapse on 22 March 2023.
-
Safety updatesHealth professionals should check if patients undergoing general anaesthesia have used products containing pholcodine in the previous 12 months.
-
News articlesThe TGA is aware of concerns about decreased effectiveness of monoclonal antibodies against the COVID-19 caused by emerging SAR-COV-2 variants. At this stage, the regulatory status of the products remain unchanged in Australia.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesIn response to user feedback, we have been trialling a beta version of the DAEN – medicines since June 2022 alongside the older database.
-
News articlesSupplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesNew guidelines and mandatory requirements for listed medicines ingredients have come into effect on 1 February 2023.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesCurrent antibiotics shortages in Australia include amoxicillin, amoxicillin/clavulanic acid, cefalexin, metronidazole and trimethoprim.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesThe Prescribing Medicines in Pregnancy database has now been updated.
-
News articlesThe Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.
-
News articlesBefore you take a weight loss supplement or medicine, there are things to consider.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
News articlesA warning to social media influencers and advertisers not to advertise this prescription medicine.